Besifloxacin
Back to searchMolecule Structure
Scientific Name
Besifloxacin
Description of the Drug
Besifloxacin is a fluoroquinolone antibiotic agent used for the treatment of bacterial conjunctivitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06771
http://www.drugbank.ca/drugs/DB06771
Brand Name(s)
Not Available
Company Owner(s)
Bausch And Lomb Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2311224 |
| Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL2363076 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL725805 | |
| DrugBank | DB06771 | |
| PubChem: Thomson Pharma | 15174158 | |
| PubChem | 10178705 | |
| Nikkaji | J2.605.468K | |
| EPA CompTox Dashboard | DTXSID00161706 | |
| DrugCentral | 4111 | |
| ChemicalBook | CB82470922 | |
| rxnorm | BESIVANCE | BESIFLOXACIN |
| ChEBI | 135622 | |
| ZINC | ZINC000003787097 |
